Table 1 Patient characteristics by sex.
From: Factors related to sex differences in long-term functional decline after acute ischemic stroke
Women | Men | P | |
|---|---|---|---|
n = 2691 | n = 4157 | ||
Age | |||
Age, y, mean ± SD | 72.0 ± 12.3 | 67.1 ± 11.4 | < 0.001 |
Old age, n (%) | 1291 (48.0) | 1140 (27.4) | < 0.001 |
Body weight | |||
Body mass index, kg/m2, mean ± SD | 23.1 ± 4.0 | 23.9 ± 3.3 | < 0.001 |
Underweight, n (%) | 245 (9.1) | 130 (3.1) | < 0.001 |
Obesity, n (%) | 737 (27.4) | 1359 (32.7) | < 0.001 |
Risk factors and comorbidities, n (%) | |||
Hypertension | 2125 (79.0) | 3320 (79.9) | 0.37 |
Diabetes mellitus | 667 (24.8) | 1390 (33.4) | < 0.001 |
Dyslipidemia | 1688 (62.7) | 2302 (55.4) | < 0.001 |
Atrial fibrillation | 464 (17.2) | 741 (17.8) | 0.54 |
Smoking | 444 (16.5) | 3246 (78.1) | < 0.001 |
Drinking | 342 (12.7) | 2327 (56.0) | < 0.001 |
Ischemic heart disease | 303 (11.3) | 595 (14.3) | < 0.001 |
Chronic kidney disease | 857 (31.8) | 1183 (28.5) | 0.003 |
Stroke characteristics, n (%) | |||
Previous history of stroke | 431 (16.0) | 782 (18.8) | 0.003 |
Cardioembolic stroke | 426 (15.8) | 618 (14.9) | 0.28 |
Severe stroke | 444 (16.5) | 456 (11.0) | < 0.001 |
Neurological impairment, n (%) | |||
Arm weakness | 627 (23.3) | 651 (15.7) | < 0.001 |
Leg weakness | 624 (23.2) | 625 (15.0) | < 0.001 |
Limb weakness | 755 (28.1) | 809 (19.5) | < 0.001 |
Aphasia | 285 (10.6) | 321 (7.7) | < 0.001 |
Medication, n (%) | |||
Antihypertensives | 1409 (52.4) | 2171 (52.2) | 0.91 |
Antidiabetics | 490 (18.2) | 1019 (24.5) | < 0.001 |
Antidyslipidemics | 1517 (56.4) | 2005 (48.2) | < 0.001 |
Antiplatelets | 2013 (74.8) | 3252 (78.2) | 0.001 |
Anticoagulants | 730 (27.1) | 1093 (26.3) | 0.45 |
Functional status at 3 months | |||
3-month mRS score, median (IQR) | 1 (0–3) | 1 (0–2) | < 0.001 |
Functional dependency, n (%) | 754 (28.0) | 566 (13.6) | < 0.001 |
